High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups

A few years ago, when Virta Health founder and CEO Sami Inkinen approached employers about leveraging the company's nutrition-oriented digital diabetes program for obesity-related weight loss, most companies weren't ready to commit. Now, more employers are all in on nutritional counseling and coaching as they grapple with rising costs for diabetes and weight loss drugs like Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and Zepbound. "Our goal is not to drive the maximum number of GLP-1 prescrip ...